NL6612958A - - Google Patents

Info

Publication number
NL6612958A
NL6612958A NL6612958A NL6612958A NL6612958A NL 6612958 A NL6612958 A NL 6612958A NL 6612958 A NL6612958 A NL 6612958A NL 6612958 A NL6612958 A NL 6612958A NL 6612958 A NL6612958 A NL 6612958A
Authority
NL
Netherlands
Application number
NL6612958A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3934465A external-priority patent/GB1123258A/en
Application filed filed Critical
Publication of NL6612958A publication Critical patent/NL6612958A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • C07D207/412Acyclic radicals containing more than six carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58Preparation of carboxylic acid halides
    • C07C51/60Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
NL6612958A 1962-12-11 1966-09-14 NL6612958A (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB46740/62A GB1069341A (en) 1962-12-11 1962-12-11 Pharmaceutical compositions containing alkanolamine derivatives
GB2871763 1963-07-19
GB4674063 1963-11-13
GB3934465A GB1123258A (en) 1965-09-15 1965-09-15 Alkanolamine derivatives

Publications (1)

Publication Number Publication Date
NL6612958A true NL6612958A (xx) 1967-03-16

Family

ID=27448750

Family Applications (2)

Application Number Title Priority Date Filing Date
NL301580D NL301580A (xx) 1962-12-11
NL6612958A NL6612958A (xx) 1962-12-11 1966-09-14

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL301580D NL301580A (xx) 1962-12-11

Country Status (9)

Country Link
US (1) US3501769A (xx)
BE (2) BE641133A (xx)
CH (3) CH528479A (xx)
DE (3) DE1493848C3 (xx)
DK (1) DK121866B (xx)
FI (1) FI42094B (xx)
GB (1) GB1069341A (xx)
NL (2) NL6612958A (xx)
SE (1) SE323085B (xx)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6504268A (xx) * 1965-04-03 1966-10-04
US3466325A (en) * 1965-04-30 1969-09-09 Haessle Ab 1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
US4036988A (en) * 1967-02-06 1977-07-19 Boehringer Ingelheim G.M.B.H. Therapeutic compositions and method
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
NL136601C (xx) * 1967-06-15
US3959359A (en) * 1968-01-23 1976-05-25 Laboratoires Laroche Navarron Phenoxyalkylamines, process for their preparation and therapeutical composition containing same
US3668206A (en) * 1968-10-16 1972-06-06 Venkatachala Lakshmi Narayanan Heterocyclic amine derivatives of 5,8-dihydronaphthyloxy propanols
CA957364A (en) * 1968-11-18 1974-11-05 Pfizer Corporation Preparation of polar-substituted phenyl propanolamines
US4018824A (en) * 1969-11-28 1977-04-19 Teikoku Hormone Mfg. Co., Ltd. 1-Aryloxy-3-aminopropane derivatives
US4360464A (en) * 1969-11-28 1982-11-23 Teikoku Hormone Mfg. Co. Ltd. Process for production of 1-aryloxy-aminopropane derivatives
US3911015A (en) * 1970-05-18 1975-10-07 Alfa Farmaceutici Spa Substituted alkanol-thio-alkylamines and salts thereof
FR2119843B1 (xx) * 1970-12-28 1974-03-22 Laroche Navarro Labo
FR2119844B1 (xx) * 1970-12-28 1974-03-22 Laroche Navarro Labo
US4038319A (en) * 1970-12-28 1977-07-26 Laboratoires Laroche Navarron Substituted phenoxyalkylamines, process for their preparation and applications thereof
GB1395156A (en) * 1971-07-28 1975-05-21 Ici Ltd Aldehyde derivatives
US3929856A (en) * 1971-12-14 1975-12-30 Parke Davis & Co 1-(3,4-Dimethoxyphenethylamino)-3-(phenoxy)-2-propanols
BE790165A (fr) * 1971-12-14 1973-02-15 Parke Davis & Co Nouveaux aminoalcanols et procede pour les preparer
SE386892B (sv) * 1972-07-06 1976-08-23 Haessle Ab Forfarande for framstellning av oxaminoforeningar
LU66207A1 (xx) * 1972-09-29 1974-04-02
DE2354444A1 (de) * 1973-10-31 1975-05-07 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
CH585693A5 (xx) * 1974-02-08 1977-03-15 Ciba Geigy Ag
SE388849B (sv) * 1974-02-14 1976-10-18 Haessle Ab Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity
US4379167A (en) * 1974-10-25 1983-04-05 A. H. Robins Company, Inc. 1-Aryloxy-4-amino-2-butanols and the pharmaceutical use thereof
US4806555A (en) * 1974-10-25 1989-02-21 A. H. Robins Company, Incorporated 1-aryloxy-4-amino-2-butanols
DE2505423A1 (de) * 1975-02-08 1976-08-19 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
US4201790A (en) * 1975-06-20 1980-05-06 May & Baker Limited Benzophenone derivatives
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives
US4119729A (en) * 1975-12-19 1978-10-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine therapeutic process
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
DE2962112D1 (en) * 1978-02-08 1982-03-25 Ici Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
US4341718A (en) * 1978-07-03 1982-07-27 American Home Products Corporation α-[(Alkylamino)-methyl]-β-aryloxy-benzeneethanols exhibiting antiarrhythmic activity
DE2839475A1 (de) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Isopropylamin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
DE2935901C2 (de) * 1979-09-05 1983-06-01 A. Nattermann & Cie GmbH, 5000 Köln 1-(2-Acetylphenylthio)-3-alkylamino-2-propanole und deren Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4604481A (en) * 1980-11-28 1986-08-05 American Hospital Supply Corporation Compounds for treatment or prophylaxis of cardiac disorders
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
JPS5832847A (ja) * 1981-08-20 1983-02-25 Mitsubishi Chem Ind Ltd (3−アミノプロポキシ)ビベンジル類
US4582855A (en) * 1981-11-12 1986-04-15 American Hospital Supply Corporation Aromatic and esters of hydroxypropylamines
DE3151201A1 (de) * 1981-12-23 1983-07-28 Beiersdorf Ag, 2000 Hamburg Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
DE3237400A1 (de) * 1982-10-08 1984-04-12 Bayer Ag, 5090 Leverkusen Substituierte 1-hydroxyethyl-triazolyl-derivate
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
US4579867A (en) * 1984-04-09 1986-04-01 American Hospital Supply Corporation Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents
NZ211815A (en) * 1984-05-15 1988-11-29 Warner Lambert Co Preparation of 1-((3,4-dimethoxyphenethyl)amino)-3- (3-tolyloxy)-2-propanol
JPS61210063A (ja) * 1985-03-14 1986-09-18 Mitsubishi Chem Ind Ltd アリ−ルスルホン類
DE3544172A1 (de) * 1985-12-13 1987-06-19 Lentia Gmbh Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung
DE3773188D1 (de) * 1987-03-26 1991-10-24 Helopharm Petrik Co Kg Verfahren zur herstellung von 5-hydroxydiprafenon und seiner salze mit saeuren.
TW275614B (xx) * 1993-02-15 1996-05-11 Senju Pharma Co
US5488064A (en) * 1994-05-02 1996-01-30 Bristol-Myers Squibb Company Benzo 1,3 dioxole derivatives
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2050441A1 (en) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB622297A (en) * 1946-12-06 1949-04-29 British Drug Houses Ltd Improvements in or relating to the preparation of basic ethers
US3033640A (en) * 1954-06-16 1962-05-08 Saul & Co Incorporation of an organic basic compound into cellulose acetate materials
DE1220440B (de) * 1962-02-14 1966-07-07 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen
US3275629A (en) * 1963-03-20 1966-09-27 Monsanto Co Substituted aryloxyalkylene amines

Also Published As

Publication number Publication date
CH528479A (de) 1972-09-30
BE686949A (xx) 1967-03-15
NL301580A (xx)
DE1493848B2 (de) 1977-11-17
DE1792711A1 (de) 1972-08-10
DE1543701A1 (de) 1972-08-10
CH461532A (de) 1968-08-31
DE1493848C3 (de) 1978-07-06
BE641133A (xx) 1964-06-11
DE1493848A1 (de) 1972-03-30
US3501769A (en) 1970-03-17
CH515212A (de) 1971-11-15
DE1792711B2 (de) 1978-06-22
DK121866B (da) 1971-12-13
GB1069341A (en) 1967-05-17
DE1792711C3 (de) 1979-02-08
FI42094B (xx) 1970-02-02
SE323085B (xx) 1970-04-27

Similar Documents

Publication Publication Date Title
FI42094B (xx)
BE616548R (xx)
BE624357A (xx)
BE614380A (xx)
BE614986A (xx)
BE613298A (xx)
BE613190A (xx)
BE613108A (xx)
BE612926A (xx)
BE633213A (xx)
BE632284A (xx)
BE631850A (xx)
BE616785A (xx)
BE630440A (xx)
BE629934A (xx)
BE629676A (xx)
BE628717A (xx)
BE628187A (xx)
BE626683A (xx)
BE614757A (xx)
BE631623A (xx)
BE615316A (xx)
BE616386A (xx)
BE616166A (xx)
BE615962A (xx)